Clinical therapeutics in pregnancy
- PMID: 21785566
- PMCID: PMC3139199
- DOI: 10.1155/2011/783528
Clinical therapeutics in pregnancy
Abstract
Most drugs are not tested for use during pregnancy, consequently, labeling, which may include information about fetal safety, includes nothing about dosing, efficacy, or maternal safety. Yet these are concerns of health care providers considering treatment of disease during pregnancy. Therefore, the practitioner treats the pregnant woman with the same dose recommended for use in adults (typically men) or may decide not to treat the disease at all. However, is the choice of not treating a woman during pregnancy better than dealing with the challenges which accompany treatment? This paper, which summarizes metabolic and physiologic changes induced by pregnancy, illustrates that standard adult dosing is likely to be incorrect during pregnancy.
References
-
- Black RA, Hill DA. Over-the-counter medications in pregnancy. American Family Physician. 2003;67(12):2517–2524. - PubMed
-
- Riley EH, Fuentes-Afflick E, Jackson RA, et al. Correlates of prescription drug use during pregnancy. Journal of Women’s Health. 2005;14(5):401–409. - PubMed
-
- Bonati M, Bortolus R, Marchetti F, Romero M, Tognoni G. Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. European Journal of Clinical Pharmacology. 1990;38(4):325–328. - PubMed
-
- Rayburn WF, Farmer KC. Off-label prescribing during pregnancy. Obstetrics and Gynecology Clinics of North America. 1997;24(3):471–478. - PubMed
-
- Rayburn WF. A physician’s prerogative to prescribe drugs for off-label uses during pregnancy. Obstetrics and Gynecology. 1993;81(6):1052–1055. - PubMed
LinkOut - more resources
Full Text Sources